Saulėtekio klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 918,306 | 986,124 | 881,661 | 1,196,061 | 1,183,228 | 1,149,488 | 1,029,731 | 890,368 |
| Profit before tax | 29,999 | 34,258 | 6,631 | 40,689 | -5,081 | 27,924 | 216,565 | -134,884 |
| Net profit | 27,183 | 31,554 | 5,798 | 37,493 | -5,739 | 25,366 | 183,188 | -134,884 |
| Equity | 660,732 | 680,286 | 673,084 | 692,577 | 672,838 | 681,204 | 864,392 | 621,508 |
| Liabilities | 168,446 | 122,420 | 298,765 | 219,672 | 112,002 | 77,790 | 83,823 | 60,925 |
| Non-current assets | 608,724 | 538,149 | 789,134 | 715,410 | 558,200 | 482,981 | 279,772 | 521,400 |
| Current assets | 219,837 | 263,987 | 181,352 | 196,336 | 226,640 | 276,013 | 668,443 | 161,033 |
| Total assets | 828,561 | 802,136 | 970,486 | 911,746 | 784,840 | 758,994 | 948,215 | 682,433 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 177,890 | 160,024 | 192,736 |
| Social insurance contributions | - | - | - | - | - | 188,581 | 176,335 | 165,903 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.7% | +7.4% | -10.6% | +35.7% | -1.1% | -2.9% | -10.4% | -13.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.3% | 3.9% | 0.6% | 4.1% | -0.7% | 3.3% | 19.3% | -19.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.1% | 4.6% | 0.9% | 5.4% | -0.9% | 3.7% | 21.2% | -21.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.0% | 3.2% | 0.7% | 3.1% | -0.5% | 2.2% | 17.8% | -15.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.3% | 3.5% | 0.8% | 3.4% | -0.4% | 2.4% | 21.0% | -15.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.4 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 22,039 | 22,845 | 21,725 | 26,878 | 30,082 | 28,677 | 30,511 | 29,272 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Saulėtekio klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-12 | 2026-05-12 | 0.01 |
| 2025-08-08 | 2025-08-12 | 106.51 |
| 2025-06-27 | 2025-07-10 | 16.21 |
| 2025-05-28 | 2025-05-29 | 80.24 |
| 2022-11-17 | 2022-11-18 | 138.64 |
Saulėtekio klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-11 | 2026-04-13 | 2.08 |
| 2026-02-21 | 2026-03-02 | 0.22 |
| 2025-05-08 | 2025-05-12 | 0.5 |
| 2025-05-06 | 2025-05-06 | 42.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sauletekio klinika, UAB (company code 121506977) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €890.4K, which was 13.5% lower year on year and 22.5% below the 2023 level. After two profitable years, performance turned negative: net profit was €25.4K in 2023 and increased sharply to €183.2K in 2024, before falling to a net loss of €134.9K in 2025. The 2025 profit margin was -15.1%. Balance sheet strength remained solid, with total assets of €682.4K, equity of €621.5K and liabilities of €60.9K. The equity ratio stood at 91.1%, while debt-to-equity was 0.10 and asset turnover 1.30x. Return on equity was -21.7% and return on assets -19.8% in 2025. Revenue per employee was €29.7K, and profit per employee was -€4.5K, indicating weaker operational results in the latest year.